VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
TEN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
TENTsakos Energy Navigation Limited
$48.27$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
TEN logo

Tsakos Energy Navigation Limited

TEN
NYSE · Midstream Oil & Gas
$48.27
At close - Sep 22, 4:00 PM EDT - USD
Market Cap$1.45B
P/E10.8x
52W High$53.84
Volume746.95K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Revenue Boom at 54% Growth Raises Sustainability Concerns

TEN is experiencing a cyclical upswing with revenue surging 54.4% in 2026Q2 and gross margin expanding to 46.8%, driven by favorable charter rates. However, the reported net income of $139.3M in that quarter includes significant non-operating gains, which may ...

GrowthAccelerating
ProfitabilityStrong
ValuationAttractive
TechnicalsStrong
Explore valuation models
MARKET ACTION

TEN price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

10/12 Beats

EPS beat 10 of last 12 quarters

02

Valuation risk

-34% Peers

P/E is 34% below peer median

03

Market leadership

RS 93 · Leader

High momentum (Outperforming 93% of market)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystConfirmed earnings · Nov 19

Market performance

Price History →

Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
TEN+127.36%
S&P 500 (^GSPC)+13.20%
1-Year Return
TEN+121.65%
S&P 500 (^GSPC)+15.98%
3-Year Return
TEN+169.25%
S&P 500 (^GSPC)+68.23%
5-Year Return
TEN+550.73%
S&P 500 (^GSPC)+60.98%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y High
10.8x
Forward P/EExpansion
5.4x
EV/EBITDA80th %ile
7.5x
FCF YieldCash Flow
N/A

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
10.8x
3.4x
100th· High
EV/EBITDA
7.5x
4.9x
80th· High
Price/FCF
N/A
6.8x
N/A
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$91.70+90.0%
Base (Fair)$168.43+223.3%
Bull$329.09+581.8%
$91.70 Bear$168.43 Base$329.09 Bull
Current Market Price: $48.27
Trades at a 71.3% discount to Base DCF ($168.43)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue
$799M-0.7% YoY
Net income
$161M-8.7% YoY
Free cash flow
-$226M+34.0% YoY
Operating margin
30.1%-4.5 pts YoY
ROIC (TTM)5.4%
Avg ROIC 5Y-
ROE (TTM)8.9%
Piotroski Score4 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate10/12 (83%)
Revenue Beat Rate11/12 (92%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Sep 10, 2026
$3.14+7.2%
vs $2.93
$246M+3.1%
vs $239M
Q2 2026
May 21, 2026
$2.72+31.4%
vs $2.07
$223M+6.9%
vs $209M
Q2 2026
Mar 6, 2026
$1.70+58.9%
vs $1.07
$195M+12.9%
vs $173M
Q4 2025
Nov 20, 2025
$1.05+36.4%
vs $0.77
$186M+14.4%
vs $163M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
GuruFocus·Sep 15, 2026
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus LAZCLUZE® (lazertinib) with prophylactic strategies shows low rates of treatment-related events at WCLC 2026

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus LAZCLUZE (lazertinib) with prophylactic strategies shows low rates of treatment-related events a

GuruFocus·Sep 14, 2026
TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial

Updated exploratory results from the ADAURA Phase III trial showed AstraZeneca's TAGRISSOÂ (osimertinib) demonstrated a sustained, clinically meaningful overal

GuruFocus·Sep 14, 2026
Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer

Johnson and Johnson's RYBREVANTÂ (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positi

Seeking Alpha·Sep 10, 2026
Tsakos Energy Navigation Limited (TEN) Q2 2026 Earnings Call Transcript

Tsakos Energy Navigation Limited (TEN) Q2 2026 Earnings Call Transcript

Filtered for Tsakos Energy Navigation LimitedMore Headlines
04

Compare before deciding

Benchmark TEN against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Tsakos Energy Navigation Limited (TEN)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
TEN logoTENTsakos Energy Navigation LimitedCurrent
$48.27$1.45B10.85-0.67%20.15%8.86%4.19%
TNK logoTNKTeekay Tankers Ltd.
$95.60$3.31B9.47-22.58%51.35%27.73%—
INSW logoINSWInternational Seaways, Inc.
$103.95$5.15B16.69-11.38%61.86%37.04%—
DHT logoDHTDHT Holdings, Inc.
$21.39$3.44B16.33-13.04%65.54%39.55%—
STNG logoSTNGScorpio Tankers Inc.
$82.33$4.1B11.71-24.58%67.16%24.51%—
NAT logoNATNordic American Tankers Limited
$7.66$1.62B132.07-16.39%33.2%26.85%—

Compare TEN vs Peers

Tsakos Energy Navigation Limited (TEN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TNK

Most directly comparable listed peer for TEN.

Scale Benchmark

vs XOM

Larger-name benchmark to compare TEN against a more recognizable public peer.

Peer Set

Compare Top 5

vs TNK, INSW, DHT, STNG

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

TEN SEC Filings & Documents

Tsakos Energy Navigation Limited (TEN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Nov 17, 2022·SEC

Material company update

Nov 14, 2022·SEC

Material company update

Nov 7, 2022·SEC

10-K Annual Reports

1
FY 2022

Feb 24, 2022·SEC

10-Q Quarterly Reports

6
FY 2022

Oct 31, 2022·SEC

FY 2022

Aug 4, 2022·SEC

FY 2022

May 5, 2022·SEC

Get notified when TEN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

TEN Frequently Asked Questions

Tsakos Energy Navigation Limited (TEN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Tsakos Energy Navigation Limited's revenue?

Tsakos Energy Navigation Limited (TEN) reported $910.9M in revenue for fiscal year 2025. This represents a 86% decrease from $6.65B in 1996.

How fast is Tsakos Energy Navigation Limited growing?

Tsakos Energy Navigation Limited (TEN) saw revenue decline by 0.7% over the past year.

Is TEN profitable?

Yes, Tsakos Energy Navigation Limited (TEN) is profitable, generating $261.9M in net income for fiscal year 2025 (20.1% net margin).

Dividend & Returns
Does TEN pay dividends?

Yes, Tsakos Energy Navigation Limited (TEN) pays a dividend with a yield of 4.19%. This makes it attractive for income-focused investors.

What is TEN's return on equity?

Tsakos Energy Navigation Limited (TEN) has a return on equity (ROE) of 8.9%. This is below average, suggesting room for improvement.

What is Tsakos Energy Navigation Limited's free cash flow?

Tsakos Energy Navigation Limited (TEN) had negative free cash flow of $575.2M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in TEN back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →